QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2015     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Is Reducing Dietary Sodium Helpful in Reducing Blood Pressure and Cardiovascular Disease Risk? An Argument Generated From the PURE Study 期刊论文 JOURNAL OF CLINICAL HYPERTENSION, 2015, 卷号: 17, 期号: [db:dc_citation_issue], 页码: 911-912 作者:  Mu, Jianjin;  Chen, Yang;  Guo, Tongshuai;  Yuan, Zuyi 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/02 An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial 会议论文 作者:  Shi, Yuankai;  Wang, Mengzhao;  He, Jianxing;  Chang, Jianhua;  Han, Baohui 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19 S-1  phase 3 trial  Therapy  NSCLC   An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 期刊论文 2015, 卷号: 33, 期号: 15 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  He, Jianxing;  Shi, Yuankai;  Chang, Jianhua;  Wang, Mengzhao;  Han, Baohui 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial 期刊论文 2015, 卷号: 10, 期号: 9, 页码: S174-S174 作者:  Shi, Yuankai;  Wang, Mengzhao;  He, Jianxing;  Chang, Jianhua;  Han, Baohui 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13 S-1  phase 3 trial  Therapy  NSCLC